Dr. Peter O'Donnell, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Chicago Hospital / Roosevelt University

  Medical School, 2003

• Clinicopathologic Features of Late Onset Veno-Occlusive Disease/Sinusoidal Obstructive Syndrome After High Dose Busulfan and Hematopoietic Cell Transplantation, 2012-03-13

• Establishment of CYP2D6 Reference Samples by Multiple Validated Genotyping Platforms, 2014-07-01

• Clinical Evaluation of Cisplatin Sensitivity Germline Polymorphisms in Neoadjuvant Chemotherapy for Urothelial Cancer, 2016-03-10

• Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy, 2009-07-21

• Patient perceptions of care as influenced by a large institutional pharmacogenomic implementation program, 2017-04-04

• Serum C-telopeptide collagen crosslinks and plasma soluble VEGFR2 as pharmacodynamic biomarkers in a trial of sequentially administered sunitinib and cilengitide, 2015-07-21

• The Role of Chemotherapy in Upper Tract Urothelial Carcinoma, 2009-01-26

• The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone, 2016-02-15

• The 1200 Patients Project: Creating A New Medical Model System for Clinical Implementation of Pharmacogenomics, 2012-08-29

• Patient-Provider Communications About Pharmacogenomic Results Increase Patient Recall of Medication Changes, 2019-02-04

• Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing, 2017-06-15

• University of Chicago Center for Personalized Therapeutics: research, education and implementation science, 2014-04-21

• Assessment of Patient Perceptions of Genomic Testing to Inform Pharmacogenomic Implementation, 2017-04-20

• Germline Polymorphisms Discovered via a Cell-based Genome-wide Approach Predict Platinum Response in Head and Neck Cancers, 2011-02-08

• Clinically Actionable Genotypes for Anti-Cancer Prescribing Among >1500 Patients with Pharmacogenomic Testing, 2022-01-28

• Comprehensive Evaluation of the Contribution of X Chromosome Genes to Platinum Sensitivity, 2011-01-20

• Adjuvant atezolizumab versus observation in muscle-invasive urothelial carcinoma (IMvigor010): a multicentre, open-label, randomised, phase 3 trial, 2021-03-12

• Pharmacogenomic-Based Decision-Support to Predict Adherence to Medications, 2020-05-25

• Utility of patient-derived lymphoblastoid cell lines as anex vivocapecitabine sensitivity prediction model for breast cancer patients, 2016-05-20

• Whole exome sequencing of muscle-invasive bladder cancer identifies recurrent mutations ofUNC5Cand prognostic importance of DNA repair gene mutations on survival, 2014-10-14

• Genome-wide Meta-analysis Identifies Variants Associated with Platinating Agent Susceptibility Across Populations, 2011-08-16

• Pharmacogenomics in Early Phase Oncology Clinical Trials: Is There a Sweet Spot in Phase II?, 2012-03-16

• A randomized phase II study of pazopanib in hormone sensitive prostate cancer: a University of Chicago Phase II Consortium/ Department of Defense Prostate Cancer Clinical Trials Consortium study, 2011-10-18

• Collaborative study from the Bladder Cancer Advocacy Network for the genomic analysis of metastatic urothelial cancer, 2022-11-04

• Effect Modification by Social Determinants of Pharmacogenetic Medication Interactions on 90-Day Hospital Readmissions within an Integrated U.S. Healthcare System, 2022-07-15

• Population differences in platinum toxicity as a means to identify novel genetic susceptibility variants, 2010-07-15

• Identification of Novel Germline Polymorphisms Governing Capecitabine Sensitivity, 2012-01-03

• Dynamic Contrast Enhanced-Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma, 2016-08-17

• Evidence for Clinical Implementation of Pharmacogenomics in Cardiac Drugs, 2015-06-10

• Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients, 2011-06-24

• Health-related Quality of Life of Patients with Locally Advanced or Metastatic Urothelial Cancer Treated with Enfortumab Vedotin after Platinum and PD-1/PD-L1 Inhibitor Therapy: Results from Cohort 1 of the Phase 2 EV-201 Clinical Trial, 2022-02-12

• Modern Developments in Germline Pharmacogenomics for Oncology Prescribing, 2022-03-18

• A Phase I Study of Continuous Infusion Cilengitide in Patients with Solid Tumors, 2010-09-14

• Saracatinib as a Metastasis Inhibitor in Metastatic Castration-Resistant Prostate Cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study, 2015-10-23

• Underrepresented patient views and perceptions of personalized medication treatment through pharmacogenomics, 2021-11-01

• Patient insights on features of an effective pharmacogenomics patient portal, 2020-06-08

• Appraisal and Development of Evidence-Based Clinical Decision Support to Enable Perioperative Pharmacogenomic Application, 2021-08-10

• Adoption of a Clinical Pharmacogenomics Implementation Program During Outpatient Care-Initial Results of The University of Chicago ‘1200 Patients Project', 2014-03-10

• Creation of a pharmacogenomics patient portal complementary to an existing institutional provider-facing clinical decision support system, 2021-08-27

• Analyzing the Clinical Actionability of Germline Pharmacogenomic Findings in Oncology, 2018-05-09

• Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status, 2020-05-16

• Pharmacogenomic genotypes define genetic ancestry in patients and enable population-specific genomic implementation, 2019-09-11

• Applicability of Pharmacogenomically Guided Medication Treatment during Hospitalization of At-Risk Minority Patients, 2021-12-10

• Anesthesia Providers as Stakeholders to Adoption of Pharmacogenomic Information in Perioperative Care, 2022-04-01

• BK Virus Infection is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell Transplants, 2009-07-09

• The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems, 2017-06-09

• Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single arm, phase 2 trial, 2016-03-04

• Time from Prior Chemotherapy Enhances Prognostic Risk Grouping in the Second-line Setting of Advanced Urothelial Carcinoma: A Retrospective Analysis of Pooled, Prospective Phase 2 Trials, 2012-11-26

• The ImPreSS Trial: Implementation of Point-of-Care Pharmacogenomic Decision Support in Perioperative Care, 2019-08-21